Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
JCO Precision Oncology|February 16, 2019
Influence of TP53 Mutation on Survival in Patients With Advanced EGFR-Mutant Non-Small-Cell Lung CancerCharu Aggarwal, Christiana W Davis, Rosemarie Mick, et al.
Scientific Reports|June 15, 2022
Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapyApurva Singh, Hannah Horng, Leonid Roshkovan, et al.
Clinical Lung Cancer|October 9, 2023
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With OligoprogressionCole Friedes, Nikhil Yegya-Raman, Siqi Zhang, et al.
The Journal of Molecular Diagnostics : JMD|August 28, 2021
Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular AnalysisJacob E Till, Taylor A Black, Caren Gentile, et al.
JCI Insight|December 20, 2019
Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLCJulia Kargl, Xiaodong Zhu, Huajia Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2017
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancerStephen J Bagley, Shawn Kothari, Charu Aggarwal, et al.
JCO Precision Oncology|July 27, 2023
Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non-Small-Cell Lung CancerCharu Aggarwal, Melina E Marmarelis, Wei-Ting Hwang, et al.
JCO Precision Oncology|June 7, 2021
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based TherapyJeffrey C Thompson, Erica L Carpenter, Benjamin A Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNAJeffrey C Thompson, Stephanie S Yee, Andrea B Troxel, et al.
JTO Clinical and Research Reports|April 8, 2022
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot StudyJeffrey C Thompson, Charu Aggarwal, Janeline Wong, et al.
Pageof 4